Suppression of CD47 reduced HCC cell proliferation, and disruption of the cathepsin S/PAR2 axis increased chemosensitivity, suggesting a role for this pathway in therapy resistance [54]. The gene discussed is CTSS; the disease is hepatocellular carcinoma.